We studied the efficacy of the combined formulation of Ku-Oketsu-zai and Sei-Netsu-zai for the erythrofacia-type eruption the atopic dermatitis patients.
Among twenty patients with erythrofacia type eruption of the atopic dermatitis, fifteen patients (75%) showed Oketsu condition and five patients (25%) did not showed. In seven patients showing Oketsu condition with constipation (46.7%), the combined formulation of Sei-Netsu-zai and To-kaku-jyoki-to was effective significantly, In eight patients showing oketsu condition without constipation (53.3%), the combined formulation of Sei-Netsu-zai and To-kaku-jyoki-to was also effective.
We should consider to use the combined formulation of Sei-Netsu-zai and To-kaku-jyoki-to for the treatment of the erythrofacia-type eruption of the atopic dermatitis.

We present a case of a patient with rapid deterioration of esophageal varices caused by portal hypertension accompanied by a large arterioportal shunt that developed after radiofrequency ablation of hepatocellular carcinoma. We used n-butyl cyanoacrylate (NBCA) as an embolic material to achieve pinpoint embolization of the shunt, because the microcatheter tip was 2 cm away from the shunt site. Under hepatic arterial flow control using a balloon catheter, the arterioportal shunt was successfully embolized with NBCA, which caused an improvement in the esophageal varices.
Aged ; Arteriovenous Fistula/etiology/radiography/*therapy ; Carcinoma, Hepatocellular/*surgery ; Catheter Ablation/*adverse effects ; Embolization, Therapeutic/*methods ; Enbucrilate/*therapeutic use ; Esophageal and Gastric Varices/etiology/*therapy ; Hepatic Artery/*abnormalities/radiography ; Humans ; Liver Neoplasms/*surgery ; Male ; Portal Vein/*abnormalities/radiography